Carper Joins Brown, Thune, Colleagues to Request Administration to Adopt Bipartisan Plan to Improve Prior Authorization in Medicare Advantage Plans

Senators push to make changes at CMS to reduce administrative burden for providers, protect seniors from unnecessary delays in access to treatment 

WASHINGTON, D.C. – U.S. Senators Tom Carper (D-Del.), Sherrod Brown (D-Ohio), John Thune (R-S.D.), and several of their colleagues yesterday sent a bipartisan letter to Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure requesting an update on CMS efforts to streamline prior authorization protocols across programs, including Medicare Advantage (MA) plans. The senators commended the Biden-Harris administration’s commitment to ensuring timely access to health care and are encouraging the administration to take additional steps to strengthen prior authorization policies and make them more efficient for all Americans, including MA beneficiaries.

“We support CMS’s efforts to protect beneficiaries, increase transparency around prior authorization requirements, and streamline prior authorization processes for patients, providers, and health plans. We request an update on CMS’s plans to revisit and advance policies to modernize and improve prior authorization for patients and providers,” wrote the senators.

The senators are encouraging the administration to use their bipartisan legislation from last congress, the Improving Seniors’ Timely Access to Care Act, as a framework to require private insurance companies that operate MA plans to adopt electronic prior authorization programs and approve medical services in a more timely manner. Prior authorization, when used appropriately, can be an important tool to ensure beneficiaries receive clinically appropriate treatments and help control the cost of care; however, when used improperly, prior authorization can lead to delays in care for patients and result in administrative burdens for providers. The Improving Seniors’ Timely Access to Care Act would help to streamline prior authorization processes, and promote safe, timely, and affordable access to evidence-based care for Medicare Advantage enrollees and the providers and suppliers who care for them. Over 400 national health organizations, including groups in Delaware, support this effort.

The letter was also signed by U.S. Senators Bob Casey (D-Pa.), Kyrsten Sinema (D-Ariz.), Roger Marshall (R-Kan.), Michael Bennet (D-Colo.), John Barrasso (R-Wyo.), Marsha Blackburn (R-Tenn.), John Boozman (R-Ark.), Catherine Cortez Masto (D-Nev.), Mike Braun (R-Ind.), Ben Ray Lujan (D-N.M.), Shelley Moore Capito (R-W.Va.), Jeff Merkley (D-Ore.), Bill Cassidy (R-La.), Jacky Rosen (D-Nev.), Susan Collins (R-Maine), Debbie Stabenow (D-Mich.), Kevin Cramer (R-N.D.), Chris Van Hollen (D-Md.), Steve Daines (R-Mont.), John Hoeven (R-N.D.), Cindy Hyde-Smith (R-Miss.), Cynthia Lummis (R-Wyo.), Jerry Moran (R-Kan.), Lisa Murkowski (R-Alaska), Mike Rounds (R-S.D.), and Roger Wicker (R-Miss.).

The full text of the bipartisan letter is available here and can be found below. 

October 28, 2021 

The Honorable Chiquita Brooks-LaSure

Administrator

U.S. Centers for Medicare & Medicaid Services

7500 Security Boulevard

Baltimore, M.D. 21244

Dear Administrator Brooks-LaSure:

We write to thank you for your commitment to ensuring timely access to health care for all Americans, and to request an update on the U.S. Centers for Medicare and Medicaid Services’ (CMS) efforts to streamline prior authorization protocols across programs. We encourage you to take additional steps to strengthen prior authorization policies and make them more efficient for all Americans, including Medicare Advantage (MA) beneficiaries.

We appreciate the recent actions CMS has taken related to prior authorization that attempt to strike a balance between program integrity and patient access to care. In December 2020, CMS issued a proposed rule to modernize processes related to prior authorization that would reduce significant burdens on health care providers and patients and improve patient outcomes.^[1] This notice of proposed rulemaking (NPRM) would have made changes to streamline prior authorization processes across Medicaid, Children’s Health Insurance Program (CHIP), and federally-facilitated exchange (FFE) plans. To our disappointment, CMS formally withdrew these proposed changes to the prior authorization process in March 2021.

More recently, CMS issued a memorandum to MA plans, strongly encouraging all MA plans to waive or relax prior authorization requirements and utilization management processes related to COVID-19.^[2] While we agree that prior authorization, when used appropriately, is an important tool for payers to manage costs and ensure program integrity, we support CMS’s efforts to protect beneficiaries, increase transparency around prior authorization requirements, and streamline prior authorization processes for patients, providers, and health plans. We request an update on CMS’s plans to revisit and advance policies to modernize and improve prior authorization for patients and providers.

As you have stated to Members of Congress, “providers and beneficiaries should not have to jump through unnecessary hoops for access to medically appropriate care.”^[3] The bipartisan, bicameral Improving Seniors’ Timely Access to Care Act proposes a balanced approach to prior authorization in the MA program that would remove barriers to patients’ timely access to care and allow providers to spend more time treating patients and less on paperwork hurdles.

We request an update on your recommended next steps for improving and streamlining prior authorization processes in a manner that benefits providers, health plans, and taxpayers, but especially beneficiaries – including MA enrollees. We urge you to build on CMS’s prior work and use your regulatory authority to improve the prior authorization process across health plans, in line with the Improving Seniors’ Timely Access to Care Act, by:

• establishing an electronic, “real-time” prior authorization process across federal programs, including MA plans;
• reducing administrative burden for both providers and health plans;
• minimizing the use of prior authorization for routinely approved items and services;
• increasing transparency around prior authorization requirements and clinical information needed to support decisions; and
• expanding beneficiary protections.

We look forward to learning more about CMS’s ongoing work to preserve timely access to medically necessary care, and we look forward to working together to streamline prior authorization protocols and implementing reforms that will improve the transparency and efficiency of prior authorization protocols in a manner that benefits beneficiaries.

Thank you again for your dedication to this matter.

Sincerely,

###